Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy

Detailed price information for Abeona Therapeutics (ABEO-Q) from The Globe and Mail including charting and trades.
The Manila Times

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in ...
Managed Healthcare Executive

2025 FDA dermatology approvals: A new gene therapy and two targeted therapies

Zevaskyn, the first gene therapy for recessive dystrophic epidermolysis bullosa, showed significant wound healing in phase 3 ...

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Detailed price information for Abeona Therapeutics (ABEO-Q) from The Globe and Mail including charting and trades.

I Survived a Dangerous and Painful Skin Disorder

ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw ...
Fierce Pharma

House endorses bill that would revive FDA's rare pediatric review voucher program

The U.S. House of Representatives has given a unanimous thumbs up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December ...
Stocks Telegraph

Abeona Therapeutics Inc. (ABEO) Jumps 9% in Pre-market: After First Patient Treatment Announcement

Summary • Abeona Therapeutics Inc. shares rose 9% in pre-market trading, reaching $5.32. • The price increase follows the ...
The American Journal of Managed Care

Gene Therapy

Progress and Challenges With Gene Therapy in Hereditary Hearing Loss ...